Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2025 / Aug / Human Cell Atlas addsSomatic Mutation Baselines
Oncology Regulation and standards Precision medicine Training and education Insights

Human Cell Atlas Adds Somatic Mutation Baselines

New insights could inform studies of early cancer development in humans

08/15/2025 News 2 min read

Share

Credit: Original image sourced from Adobe Stock

An international team of researchers has published a comprehensive analysis of somatic mutation rates across the human body, offering new insights into how mutations accumulate in normal tissues and vary by cell type, age, and environment. The study, published in Nature, analyzed 3,127 microdissected samples from 941 donors spanning 41 tissue types, making it one of the largest studies to date on tissue-wide somatic mutation patterns.

The research was part of the Human Cell Atlas and utilized whole-genome sequencing to detect somatic single-nucleotide variants (SNVs), indels, copy number changes, and structural variants. The team applied laser-capture microdissection to isolate histologically defined units – such as crypts, ducts, and glands – from fresh-frozen tissues obtained from organ donors of varying ages, from newborns to centenarians.

One of the central findings is that somatic mutation rates vary by over two orders of magnitude between tissues. For example, intestinal crypts accumulated mutations at a rate of approximately 52 SNVs per cell per year, whereas tissues such as cardiac muscle showed much lower mutation rates. The accumulation of mutations was generally linear with age across most tissues, though with variable slopes, suggesting differences in stem cell dynamics and DNA repair efficiency.

Environmental exposures also influenced mutation rates and signatures. For instance, skin and esophageal samples displayed patterns consistent with UV and tobacco-related damage, respectively. In contrast, some tissues, including brain and muscle, showed few exogenous mutational signatures, aligning with their lower cell turnover rates.

The study also reported that many mutations accumulated without evidence of clonal expansion or driver gene selection, although certain tissues – such as endometrium, esophagus, and bladder – showed positive selection for cancer-associated mutations even in the absence of malignancy.

The researchers identified over 70 distinct mutational signatures and observed tissue-specific differences in the prevalence and combination of these signatures. A subset of donors had hypermutated tissues, often due to underlying genetic defects in DNA repair pathways, such as mismatch repair deficiency, even in the absence of a cancer diagnosis.

The findings provide a reference map for somatic mutagenesis in normal human tissues and may aid in distinguishing early neoplastic changes from background mutation accumulation. The authors note that this baseline can help inform studies of cancer development, aging, and regenerative medicine, as well as the interpretation of somatic mutations in non-tumor contexts. Data from the project are expected to contribute to public databases as part of broader efforts to build comprehensive tissue and cell atlases.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Global Referral
Research and Innovations
Global Referral

January 12, 2024

10 min read

How digital pathology is transforming the delivery of remote second opinions

Research Roundup
Research and Innovations
Research Roundup

January 31, 2024

1 min read

From spatial transcriptomics to AI diagnosis, we bring you the latest news in pathology and laboratory medicine

Flexible Solutions With FlexVUE
Research and Innovations
Flexible Solutions With FlexVUE

December 29, 2021

1 min read

Quickly customize your immune panels with Ultivue’s new innovation

Defining the Next Generation of NGS
Research and Innovations
Defining the Next Generation of NGS

December 31, 2021

1 min read

Overcoming challenges of the typical NGS workflow with the Ion Torrent™ Genexus™ System

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.